Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,683 | 82 | 99.2% |
| Education | $13.89 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $297.90 | 14 | $0 (2024) |
| Abbott Laboratories | $277.54 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $181.40 | 10 | $0 (2024) |
| Novo Nordisk Inc | $154.27 | 4 | $0 (2024) |
| Amgen Inc. | $118.15 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $106.83 | 5 | $0 (2023) |
| IBSA Pharma Inc. | $106.72 | 7 | $0 (2024) |
| ABBVIE INC. | $61.13 | 3 | $0 (2022) |
| Currax Pharmaceuticals LLC | $58.77 | 4 | $0 (2022) |
| PFIZER INC. | $43.37 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $419.75 | 20 | Abbott Laboratories ($106.01) |
| 2023 | $354.69 | 19 | Abbott Laboratories ($79.82) |
| 2022 | $492.40 | 25 | IBSA Pharma Inc. ($91.90) |
| 2021 | $238.74 | 14 | Lilly USA, LLC ($52.14) |
| 2020 | $59.59 | 3 | Novo Nordisk Inc ($20.81) |
| 2018 | $97.12 | 1 | Novo Nordisk Inc ($97.12) |
| 2017 | $34.91 | 1 | SANOFI-AVENTIS U.S. LLC ($34.91) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: ANTIBIOTIC | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Obesity | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Diabetes Care | ||||||
| 05/30/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ANTIBIOTIC | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Elastography | ||||||
| 05/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes Care | ||||||
| 04/29/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Endocrinology | ||||||
| 04/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Bone Health | ||||||
| 03/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Diabetes Care | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: PAIN | ||||||
| 01/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Diabetes Care | ||||||
| 10/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: VACCINES | ||||||
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 428 | 734 | $101,926 | $59,242 |
| 2022 | 15 | 481 | 764 | $100,733 | $60,123 |
| 2021 | 14 | 450 | 800 | $99,445 | $57,748 |
| 2020 | 13 | 454 | 793 | $87,623 | $51,831 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 137 | $23,975 | $12,793 | 53.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 48 | $10,800 | $6,426 | 59.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 92 | $9,680 | $5,879 | 60.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 41 | $11,685 | $5,743 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $6,642 | $5,353 | 80.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 52 | $7,800 | $4,998 | 64.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 72 | $9,000 | $4,526 | 50.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 85 | $6,800 | $4,232 | 62.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 30 | 45 | $7,200 | $4,164 | 57.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $2,340 | $1,870 | 79.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 44 | $3,300 | $1,771 | 53.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,092 | $813.28 | 74.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $1,300 | $450.06 | 34.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $312.00 | $223.80 | 71.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 103 | $18,025 | $9,821 | 54.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 107 | $16,050 | $8,858 | 55.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 42 | 127 | $9,620 | $6,161 | 64.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 38 | $10,830 | $6,098 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 79 | $9,875 | $5,433 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $6,318 | $5,233 | 82.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 28 | $6,300 | $4,142 | 65.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 45 | $7,200 | $3,753 | 52.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 50 | $5,000 | $2,883 | 57.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 35 | $2,800 | $2,399 | 85.7% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 15 | 21 | $2,916 | $2,158 | 74.0% |
About Dr. Kelly Englund, MD
Dr. Kelly Englund, MD is a Internal Medicine healthcare provider based in Cypress, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144251406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Englund, MD has received a total of $1,697 in payments from pharmaceutical and medical device companies, with $419.75 received in 2024. These payments were reported across 83 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,683).
As a Medicare-enrolled provider, Englund has provided services to 1,813 Medicare beneficiaries, totaling 3,091 services with total Medicare billing of $228,944. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cypress, TX
- Active Since 07/05/2006
- Last Updated 06/24/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144251406
Products in Payments
- MOUNJARO (Drug) $206.25
- FREESTYLE LIBRE 3 (Device) $185.83
- FARXIGA (Drug) $145.25
- Ozempic (Drug) $117.93
- Kerendia (Drug) $106.83
- Tirosint (Drug) $106.72
- EVENITY (Biological) $104.26
- NURTEC ODT (Drug) $65.87
- CONTRAVE (Drug) $58.77
- FREESTYLE LIBRE (Device) $46.20
- TRULICITY (Drug) $46.13
- EMGALITY (Drug) $45.52
- QULIPTA (Drug) $44.39
- Dexcom G6 Transmitter (Medical Supply) $38.62
- AIRSUPRA (Drug) $36.15
- UBRELVY (Drug) $35.34
- SOLIQUA (Drug) $34.91
- NUZYRA (Drug) $33.04
- SHINGRIX (Biological) $32.94
- PAXLOVID (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cypress
Peter Winkle, Md, MD
Internal Medicine — Payments: $796,502
Dr. Sreedhar Gottiparthy, Md, MD
Internal Medicine — Payments: $24,448
Dr. Thuan Nguyen, M.d, M.D
Internal Medicine — Payments: $17,416
Amir Gahremanpour, M.d, M.D
Internal Medicine — Payments: $15,168
Mustafa Alqaysi, M.d, M.D
Internal Medicine — Payments: $14,996
Dr. Lisa Chan, M.d, M.D
Internal Medicine — Payments: $12,789